- Home
- GPUS vs ENSC Comparison
GPUS vs ENSC Comparison
Compare GPUS & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPUS
- ENSC
- Stock Information
- Founded
- GPUS 1969
- ENSC 2003
- Country
- GPUS United States
- ENSC United States
- Employees
- GPUS N/A
- ENSC N/A
- Industry
- GPUS
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- GPUS
- ENSC Health Care
- Exchange
- GPUS NYSE
- ENSC Nasdaq
- Market Cap
- GPUS 4.1M
- ENSC 7.9M
- IPO Year
- GPUS 1996
- ENSC N/A
- Fundamental
- Price
- GPUS $3.78
- ENSC $5.80
- Analyst Decision
- GPUS
- ENSC
- Analyst Count
- GPUS 0
- ENSC 0
- Target Price
- GPUS N/A
- ENSC N/A
- AVG Volume (30 Days)
- GPUS 60.6K
- ENSC 58.7K
- Earning Date
- GPUS 11-19-2024
- ENSC 03-14-2025
- Dividend Yield
- GPUS N/A
- ENSC N/A
- EPS Growth
- GPUS N/A
- ENSC N/A
- EPS
- GPUS N/A
- ENSC N/A
- Revenue
- GPUS $139,425,000.00
- ENSC $4,421,404.00
- Revenue This Year
- GPUS N/A
- ENSC $89.78
- Revenue Next Year
- GPUS N/A
- ENSC N/A
- P/E Ratio
- GPUS N/A
- ENSC N/A
- Revenue Growth
- GPUS 3.50
- ENSC 40.41
- 52 Week Low
- GPUS $3.09
- ENSC $2.12
- 52 Week High
- GPUS $35.89
- ENSC $17.25
- Technical
- Relative Strength Index (RSI)
- GPUS N/A
- ENSC 35.65
- Support Level
- GPUS N/A
- ENSC $5.55
- Resistance Level
- GPUS N/A
- ENSC $6.46
- Average True Range (ATR)
- GPUS 0.00
- ENSC 0.62
- MACD
- GPUS 0.00
- ENSC -0.13
- Stochastic Oscillator
- GPUS 0.00
- ENSC 7.31
About GPUS HYPERSCALE DATA INC
Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.